HealthEquity (NASDAQ:HQY) Price Target Lowered to $123.00 at JPMorgan Chase & Co.

HealthEquity (NASDAQ:HQY) had its target price lowered by JPMorgan Chase & Co. from $129.00 to $123.00 in a report released on Wednesday morning,Benzinga reports. The firm currently has an overweight rating on the stock.

Several other analysts have also weighed in on HQY. KeyCorp raised their price objective on shares of HealthEquity from $120.00 to $125.00 and gave the stock an “overweight” rating in a report on Thursday, January 8th. BMO Capital Markets set a $85.00 target price on HealthEquity in a report on Tuesday, February 24th. UBS Group set a $110.00 price target on HealthEquity in a research report on Tuesday, February 17th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of HealthEquity in a report on Thursday, January 22nd. Finally, Barrington Research cut their price objective on HealthEquity from $125.00 to $110.00 and set an “outperform” rating for the company in a research report on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, HealthEquity has an average rating of “Moderate Buy” and a consensus price target of $109.79.

HealthEquity Stock Up 0.2%

Shares of NASDAQ:HQY opened at $79.57 on Wednesday. The company’s fifty day moving average is $80.93 and its 200-day moving average is $90.20. The company has a debt-to-equity ratio of 0.46, a quick ratio of 4.13 and a current ratio of 4.13. HealthEquity has a 52 week low of $72.76 and a 52 week high of $116.65. The company has a market capitalization of $6.80 billion, a PE ratio of 32.35, a P/E/G ratio of 0.99 and a beta of 0.26.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Tuesday, March 17th. The company reported $0.95 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.05. HealthEquity had a net margin of 16.39% and a return on equity of 13.82%. The business had revenue of $334.59 million during the quarter, compared to analysts’ expectations of $332.48 million. The company’s revenue for the quarter was up 7.3% compared to the same quarter last year. Equities research analysts predict that HealthEquity will post 2.32 earnings per share for the current fiscal year.

Insider Activity

In other news, EVP Delano Ladd sold 1,500 shares of the company’s stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $94.72, for a total transaction of $142,080.00. Following the transaction, the executive vice president directly owned 73,979 shares in the company, valued at approximately $7,007,290.88. This represents a 1.99% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 1.50% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of HQY. Acumen Wealth Advisors LLC bought a new position in HealthEquity in the 4th quarter valued at $27,000. Aster Capital Management DIFC Ltd bought a new stake in shares of HealthEquity during the fourth quarter worth $28,000. Caitong International Asset Management Co. Ltd raised its position in shares of HealthEquity by 1,723.5% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock worth $28,000 after acquiring an additional 293 shares during the last quarter. True Wealth Design LLC lifted its stake in shares of HealthEquity by 3,522.2% during the third quarter. True Wealth Design LLC now owns 326 shares of the company’s stock valued at $31,000 after acquiring an additional 317 shares during the period. Finally, Farther Finance Advisors LLC boosted its holdings in HealthEquity by 59.3% in the third quarter. Farther Finance Advisors LLC now owns 392 shares of the company’s stock valued at $37,000 after acquiring an additional 146 shares during the last quarter. Institutional investors own 99.55% of the company’s stock.

Key Headlines Impacting HealthEquity

Here are the key news stories impacting HealthEquity this week:

• Positive Sentiment: Q4 results beat expectations and management raised guidance — HQY reported $0.95 EPS vs. $0.90 consensus and revenue of $334.6M (vs. ~$332.5M expected); revenue was up ~7% y/y and the company raised fiscal 2027 outlook after record revenue and net income growth. Press Release
• Positive Sentiment: Earnings call highlighted operational strength — company cited record HSA growth and “improved cash economics” and other call takeaways that support the raised guidance and margin expansion. Earnings Highlights
• Positive Sentiment: Independent upgrade — Seeking Alpha published a rating upgrade citing improved cash dynamics, which can support investor sentiment and multiple expansion. SA Upgrade
• Neutral Sentiment: Full earnings/transcript availability — multiple transcripts and analyst writeups are live (useful for digging into guidance, margins, and HSA metric details). Earnings Transcript
• Negative Sentiment: Barrington trimmed its price target from $125 to $110 (still an “outperform”) — the cut narrows analyst-implied upside vs. prior target and may cap near-term upside. Benzinga Note
• Negative Sentiment: JPMorgan lowered its target from $129 to $123 but remains “overweight” — another downward revision in targets that could weigh on sentiment despite maintaining a positive rating. Benzinga TickerReport
• Negative Sentiment: RBC cut its target from $110 to $100 (still “outperform”) — another analyst trimming targets, which may limit immediate upside until guidance execution is proven. Benzinga Note

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.